Citing RPwD Act, Court of Chief Commissioner for PwDs has directed full compliance with accommodations suggested in medical certificate & law, asked to ‘sensitise officials’.

The Defense Department has spent more than a year testing a device purchased in an undercover operation that some investigators think could be the cause of a series of mysterious ailments impacting US ...

The FDA cleared an electroencephalography (EEG) system based on a small sensor worn in the ear, allowing patients to be monitored outside of hospital settings, Naox Technologies in Paris, announced on ...

Meet the Razr Fold: Motorola’s First Foldable Phone Powered by On-Device AI Your email has been sent Motorola is officially entering the foldable race. At CES 2026, the company unveiled the razr fold, ...

Naox Technologies has become the first medtech company to receive FDA clearance for its in-ear EEG device that can negate the need for complex and limited scalp electrodes that have been used for ...

LAS VEGAS, Jan. 6, 2026 /PRNewswire/ -- Tenstorrent unveiled its first-generation compact AI accelerator device designed in partnership with Razer™, the leading brand for gamers, today at CES 2026.

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...

Stephanie Palazzolo writes at The Information: OpenAI is taking steps to improve its audio AI models, in preparation for its eventual release of an AI-powered personal device, said a person with ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...

OpenAI has moved production of its first AI-powered consumer device from Luxshare to Foxconn, largely due to concerns about manufacturing in mainland China, reported Taiwan-based outlet UDN, citing ...

The FDA on Thursday approved a transcranial direct current stimulation (tDCS) device as the first at-home non-drug therapy for major depression in adults, maker Flow Neuroscience announced. Dubbed ...